Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
format_facet:"Aufsätze"
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
PubPharm (3.992)
1
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A study investigating Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) for the treatment of patients with Myasthenia Gravis, dependent on Corticosteroids. The patients will receive 2g/kg of IP as a loading dose. The loading dosage is followed by maintenance doses of 1 g/kg administered every third week until Visit 13 (Week 36). During maintenance doses the investigator will try to slowly reduce the patient's corticosteroid dose. : A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/ chromatography Purified (lGIV -C) as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients with Generalized Myasthenia Gravis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to assess the safety and efficacy of dexamethasone plus MLN9708 or physician choice of treatment in patients with relapsed or refractory amyloidosis. : A Phase 3 Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
SHP640 in the Treatment of Adenoviral Conjunctivitis : A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Bortezomib, Selinexor and Dexamethasone in Patients with Multiple Myeloma : A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) - BOSTON
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Clinical Study of Daratumumab Subcutaneous (Dara-SC) Administration in Combination with Carfilzomib and Dexamethasone (DKd) Compared with Carfilzomib and Dexamethasone (Kd) in Participants with Multiple Myeloma who have been Previously Treated with Daratumumab Intravenous (Dara-IV) to Evaluate Daratumumab Retreatment : A Phase 2 Study of Daratumumab Subcutaneous (Dara-SC) Administration in Combination with Carfilzomib and Dexamethasone (DKd) Compared with Carfilzomib and Dexamethasone (Kd) in Participants with Multiple Myeloma who have been Previously Treated with Daratumumab Intravenous (Dara-IV) to Evaluate Daratumumab Retreatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A study evaluating safety and efficacy of Itacitinib in combination with corticosteroids for the treatment of first-line acute graft versus-host disease in children : An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Pediatric Subjects
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[400]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
Aufsätze
3.992
E-Artikel
3.992
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
3.992
610
Recruitment Status: Not yet recruiting
3.896
Study Type: Interventional
1.132
Phase: Phase 3
614
Phase: Phase 2
238
Phase: Phase 4
150
Medical Condition: Health Condition 1: O- Medic...
118
Phase: Phase 1
76
Study Type: Observational
58
Medical Condition: Asthma MedDRA version: 18.1L...
44
Medical Condition: Asthma MedDRA version: 20.0L...
40
Phase: Phase 2/Phase 3
30
Medical Condition: Relapsed and/or Refractory M...
28
Medical Condition: Asthma MedDRA version: 14.1L...
26
Medical Condition: Asthma
22
Medical Condition: corticosteroid-refractory ac...
20
Medical Condition: Asthma MedDRA version: 16.0L...
20
Medical Condition: Persistent asthma MedDRA ver...
20
Medical Condition: corticosteroid refractory ch...
20
Phase: Other
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.902
2020-
2.090
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.938
Englisch
24
Spanisch
20
Unbestimmt
4
Französisch
4
Deutsch
2
Tschechisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...